See inside every stock. Pro
WatchlistPro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.44▲ 3.99%

Direxion Daily S&P Biotech Bull 3X (LABU)

Leveraged ETF · Direxion · NYSE ARCA · 163 holdings
$229.18 ▼ -5.00 (2.14%)
At close · USD · Volume 363,519
Returns and riskCostIncomeDividend historyHoldingsQuestions
52-week range
$108.90 – $341.93
Day's range
$220.35 – $241.24
1-year total return
+103.7%
Leveraged fund (3x, by its name). The stated multiple applies to one day. It resets daily, so returns over longer periods can differ a lot from the multiple, and the figures below describe the past only.

LABU price chart

Daily, split-corrected, distributions markedEnd-of-day prices

LABU fund facts

FundDirexion Daily S&P Biotech Bull 3X Shares
TickerLABU · NYSE ARCA
Issuer (by our rules)Direxion
Category (by our rules)Leveraged
Expense ratioNot in our sources
Holdings163
Net assets (fund, SEC)$494M
Yield (last 12 months)0.40%
DistributionsQuarterly
52-week range$108.90 – $341.93
Average volume (3 months)402,712
First price in our data28 May 2015
Issuer and category are assigned by StocksXray rules from the fund name. Expense ratio and net assets come from SEC filings; where a fund does not file them (for example grantor trusts) the field stays empty.

Returns and risk

1 month
−20.7%
3 months
−9.7%
6 months
+12.3%
Year to date
+43.8%
1 year
+103.7%
3 years a year
+60.3%
5 years a year
−26.1%
10 years a year
−10.3%
Volatility (1 year)
86.5%
Largest drop, last year
−41.8%
Largest drop in our data
−99.2%
Total return includes distributions, from end-of-day prices adjusted for splits and distributions, to 22 Oct 2026. Periods of 3 years and longer are annualised and shown only when the fund's history is long enough. Volatility is the standard deviation of daily returns over the last year, annualised. Past performance does not guarantee future results.

Cost: expense ratio

We could not match an expense ratio for LABU in the SEC prospectus data we read. Funds structured as trusts or notes, and very new funds, are often missing. We show nothing rather than a guess; the issuer's fact sheet has the figure.

Income: distributions

Paid, last 12 months
0.91 USD
Yield on today's price
0.40%
Frequency
Quarterly
Latest ex-date
23 Dec 2025
Full LABU dividend history →
Cash paid per current share (restated for share splits), before tax, from EODHD.

LABU top holdings

#HoldingWeight
1 DREYFUS 15.86%
2 GOLDMAN FINANCIAL 14.83%
3 N/A 9.63%
4 N/A 7.30%
5 GOLDMAN SACHS LIQ ES FD A 5.35%
6 N/A 4.85%
7 N/A 3.87%
8 APOGEE THERAPEUTICS INC 1.11%
9 ORUKA THERAPEUTICS INC 1.03%
10 DIANTHUS THERAPEUTICS INC 0.96%
The top 10 make up 64.8% of the fund, out of 163 holdings.
Positions as of 31 Jul 2026, from the fund's Form N-PORT filed with the SEC. Public N-PORT holdings are quarter-end positions published about 60 days later, so they can be months old and the fund may have changed since.

Similar Leveraged ETFs

USD ProShares Ultra Semiconductors+46.8% 1y ETHU 2x Ether2.97% fee · −77.2% 1y PTIR GraniteShares 2x Long PLTR Dai...1.04% fee · −19.2% 1y INTW GraniteShares 2x Long INTC Dai...1.50% fee · +165.1% 1y GLL ProShares UltraShort Gold−7.6% 1y FNGU MicroSectors FANG+ 3X Leverage...+2.5% 1y All leveraged ETFs →
Funds of the same category, nearest in trading size. Similar does not mean equivalent: check holdings and costs.

LABU: frequently asked questions

What is LABU?

LABU is the Direxion Daily S&P Biotech Bull 3X ETF, issued by Direxion, listed on NYSE ARCA. By our rules it is classed as "Leveraged". Its latest SEC filing lists 163 holdings.

Does LABU pay dividends?

Yes. LABU paid 0.91 per share over the last 12 months, quarterly, a trailing yield of 0.40% on today's price. The latest ex-dividend date was 23 Dec 2025.

What does LABU hold?

The largest holdings in the latest SEC filing are DREYFUS (15.9%), GOLDMAN FINANCIAL (14.8%), N/A (9.6%). The top 10 together make up 64.8% of the fund.

How has LABU performed?

Total return including distributions to 22 Oct 2026: 1 year +103.7%, 3 years +60.3% a year, 5 years −26.1% a year. Past performance does not guarantee future results.

Is LABU leveraged?

By its name LABU aims for 3x the daily return of its target. The multiple resets every day, so returns over weeks or months can differ a lot from the stated multiple, and losses can compound. Funds like this are designed for short holding periods.

Where the numbers come from

Prices and distributions end-of-day data from EODHD; returns are our own calculations from it.
Expense ratio and holdings SEC filings (prospectus risk/return data and Form N-PORT).
Category, issuer and leverage assigned by StocksXray rules from the fund name.
X-Ray look-through our scores applied to the SEC holdings.
Read the methodology →

StocksXray is for education only and is not financial advice or a recommendation to buy or sell anything. Past performance does not guarantee future results; funds can lose value.